Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Bioxcel Therapeutics Inc

CUSIP: 09075P954 | 2 institutional holders

Quarters

Q4 2025 Q3 2025 Q2 2025 Q1 2025

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile